3rd generation glp 1 agonist GLP-1 Agonists - What is it? Science's 2023 Breakthrough: GLP-1R Agonists

Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts

A systematic review pooling data from 27,617 patients found that semaglutide use lowered MACE risk by 19% overall (RR 0.81)

Some steer workers elsewhere: 15 percent encourage the use of a health care spending account, and 2 percent point employees to a direct-to-consumer platform

G., & Ramasamy, A

Back Habener, JF (2024) 'Acknowledgements' 2024 Lasker-DeBaley Clinical Medical Research Award

The study, published in Annals of Internal Medicine , found that people with type 2 diabetes who started taking GLP-1 receptor agonists were slightly more likely to develop ischemic optic neuropathy (ION) than those prescribed other diabetes drugs